Skip to main content

Table 1.

Clinicopathologic parameters of esophageal squamous cell carcinoma (ESCC) patients and the correlation with p53 gene mutation in ESCC samples

Characteristic Patients P P53 gene mutation (N = 75) P
Total N = 75 (%) Positive N = 34 (%) Negative N = 41 (%)
Gender P = 0.121
 Male 71 (94.7) 34 (100) 37 (90.2)
 Female  4 (5.3)  0  4 (9.8)
Stage P = 0.959
 I  6 (8.0)  2 (5.9)  4 (9.8)
 IIA 23 (30.7) 10 (29.4) 13 (31.7)
 IIB 17 (22.7)  8 (23.5)  9 (22.0)
 III 27 (36.0) 13 (38.2) 14 (34.1)
 IV  2 (2.7)  1 (2.9)  1 (2.4)
Depth of invasion P = 0.927
 T1  8 (10.7)  3 (8.8)  5 (12.2)
 T2 28 (37.3) 13 (38.2) 15 (36.6)
 T3 37 (49.3) 17 (50.0) 20 (48.8)
 T4  2 (2.7)  1 (2.9)  1 (2.4)
Node involvement P = 0.585
 Absence 29 (38.7) 12 (35.3) 17 (41.5)
 Presence 46 (61.3) 22 (64.7) 24 (58.5)
Cigarette P < 0.001 P = 0.123
 Smoker 63 (84.0) 31 (91.2) 32 (78.0)
 Non‐smoker 12 (16.0)  3 (8.8)  9 (22.0)
Alcohol P = 0.004 P = 0.512
 Drinker 50 (66.7) 24 (70.6) 26 (63.4)
 Non‐drinker 25 (33.3) 10 (29.4) 15 (36.6)
Betel quid chewing P = 0.908 P = 0.007
 Chewer 38 (50.7) 23 (67.6) 15 (36.6)
 Non‐chewer 37 (49.3) 11 (32.4) 26 (63.4)